AstraZeneca Pharmaceutical

FDA approves 1st at-home flu vaccine in U.S., a nasal spray

US FDA approves AstraZeneca's self-administered nasal spray flu vaccine

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind.

Seattle Times · 1d

Nasal flu vaccine is approved for at-home use

The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

CNN on MSN · 2d

FDA approves first flu vaccine that can be self-administered at home

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

FiercePharma7d

ESMO: AstraZeneca's Imfinzi extends life in bladder cancer type. Will FDA push back on its perioperative trial design?

AstraZeneca’s Imfinzi recently became the first PD-1/L1 inhibitor to deliver a patient survival win in muscle-invasive ...

Zacks.com on MSN1d

Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights

The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...

12d

AstraZeneca stock drops after lung cancer drug trial setback

London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that ...

FiercePharma2d

Johnson & Johnson tacks on another NSCLC approval in pursuit of AstraZeneca's Tagrisso

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...

2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again

Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

Zacks.com on MSN2d

Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs

This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

OpenSecrets.org4d

PAC Profile: AstraZeneca Pharmaceuticals

*Based on data released by the Federal Election Commission on September 18, 2024 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...

STAT6d

The essential biotech updates of the day

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

Investors Chronicle2d

Why 'Big Pharma' will be the next China trade war battleground

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

devdiscourse7h

Regulatory Milestones and Health Advances: Key Developments in the Pharmaceutical Sector

Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

6don MSN

Direct tumor radiation: can pharma’s $10 billion bet transform cancer treatment?

Pharmaceutical heavyweights like Bristol Myers Squibb, AstraZeneca, and Eli Lilly are betting big on radiopharmaceuticals, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results